Overview

PP100-01 (Calmangafodipir) for Overdose of Paracetamol

Status:
Completed
Trial end date:
2018-11-08
Target enrollment:
Participant gender:
Summary
Investigate the safety and tolerability of PP100-01 add-on treatment to the 12hr NAC treatment regime in patients treated for paracetamol/acetaminophen overdose (POD) when NAC treatment is initiated before 24hours post POD.
Phase:
Phase 1
Details
Lead Sponsor:
Egetis Therapeutics
PledPharma AB
Collaborators:
NHS Lothian
University of Edinburgh
Treatments:
Acetaminophen
Acetylcysteine
Edetic Acid
N-monoacetylcystine
Pyridoxal Phosphate